000 | a | ||
---|---|---|---|
999 |
_c18706 _d18706 |
||
003 | OSt | ||
005 | 20230124164429.0 | ||
008 | 230124b xxu||||| |||| 00| 0 eng d | ||
040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
100 |
_919749 _aAl Jumaili, Wisam |
||
245 | _aReview of the long-term effect of the atypical antipsychotic medication on the bone mineral density of the pediatric patient with consideration of autism spectrum disorder | ||
250 | _aVol.13(1), Mar | ||
260 |
_aNew Delhi _bSAGE _c2022 |
||
300 | _a24-30p. | ||
520 | _aObjectives: To shed some light on the understudied complication of chronic prolonged exposure to antipsychotics (AP) in children with consideration to with autism spectrum disorder (ASD). Methods: We electronically searched PubMed, Google Scholar, clinical trial.gov, and Medline Database of clinical studies up to June 2021. We used the following keywords: “bone mineral density, osteoporosis, osteopenia, bone loss, bone changes” AND “antipsychotics, SGAs, atypical antipsychotics” AND “pediatric, adolescent, young, youth, children.” We used [Mesh] Term for “antipsychotics agent” and “bone mineral density” and “autism spectrum disorder” and “child.” We retrieved relevant observational studies, reviews, case series, and randomized clinical trials. Results: Yvette Roke et al., in 2012, reported in a retrospective observational study that lumbar spine bone mineral density (BMD) and the biochemical bone marker were lower in the AP-treated boy with hyperprolactinemia in comparison to the non-AP-treated group, while a retrospective observational study of institutional adolescents with a psychiatric condition, carried out by Bonnot et al. in 2011, found significant vitamin D deficiency in psychiatric inpatient adolescents that is unrelated to the specific APs. Third, Calarge et al. in a 2010 retrospective observational study have reported a significant reduction in BMD in adolescents with risperidone-induced hyperprolactinemia and selective serotonin reuptake inhibitor (SSRI) compared to another group with risperidone-induced hyperprolactinemia without SSRI. On the other hand, Nivin A. Nagiub et al. (2019) in the cross-sectional study found no correlation between BMD and AP use in children with ASD. Houghton et al., in 2021, found a high fracture prevalence of 38% with aripiprazole compared to risperidone in children with ASD. | ||
650 | 0 |
_94774 _aPHARMACOLOGY |
|
700 |
_919750 _aMuzwagi, Ashraf |
||
773 | 0 |
_x0976-500X _tJournal of pharmacology and pharmacotherapeutics _dNew Delhi SAGE Publications |
|
856 |
_uhttps://journals.sagepub.com/doi/full/10.1177/0976500X221080296 _yClick here |
||
942 |
_2ddc _cAR |